These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35446936)

  • 1. Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia.
    Goronkova O; Novichkova G; Salimova T; Kalinina I; Baidildina D; Petrova U; Antonova K; Sadovskaya M; Suntsova E; Evseev D; Matveev V; Venyov D; Khachatryan L; Litvinov D; Pshonkin A; Ovsyannikova G; Kotskaya N; Gobadze D; Olshanskaya Y; Popov A; Raykina E; Mironenko O; Voronin K; Purbueva B; Boichenko E; Dinikina Y; Guseynova E; Sherstnev D; Kalinina E; Mezentsev S; Streneva O; Yudina N; Plaksina O; Erega E; Maschan M; Maschan A
    Blood Adv; 2023 Mar; 7(6):953-962. PubMed ID: 35446936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontline Therapy Options for Adults With Newly Diagnosed Severe Aplastic Anemia: Intensive immunosuppressive Therapy Plus Eltrombopag or Matched Sibling Donor Hematopoietic Stem Cell Transplantation?
    Huang LF; Li L; Jia JS; Yang Y; Lin SY; Meng FK; Zhang DH; He GS
    Transplant Cell Ther; 2022 Sep; 28(9):586.e1-586.e7. PubMed ID: 35609866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemia.
    Assi R; Garcia-Manero G; Ravandi F; Borthakur G; Daver NG; Jabbour E; Burger J; Estrov Z; Dinardo CD; Alvarado Y; Hendrickson S; Ferrajoli A; Wierda W; Cortes J; Kantarjian H; Kadia TM
    Cancer; 2018 Nov; 124(21):4192-4201. PubMed ID: 30307606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of immunosuppressive therapy with or without eltrombopag in pediatric patients with acquired aplastic anemia: A Chinese retrospective study.
    Fang M; Song H; Zhang J; Li S; Shen D; Tang Y
    Pediatr Hematol Oncol; 2021 Oct; 38(7):633-646. PubMed ID: 33724146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
    Zhang X; Li Z; Geng W; Song B; Wan C
    Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response To Immunosuppressive Therapy In Patients Of Acquired Aplastic Anaemia: A Single Center Experience From A Developing Country.
    Khan M; Iftikhar R; Chaudhry QU; Mehmood SK; Faraz T; Ghafoor T; Shahbaz N; Khan MA; Shamshad GU; Khattak TA
    J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S969-S973. PubMed ID: 36550655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eltrombopag in children with severe aplastic anemia.
    Lesmana H; Jacobs T; Boals M; Gray N; Lewis S; Ding J; Kang G; Hale M; Weiss M; Reiss U; Wang W; Wlodarski M
    Pediatr Blood Cancer; 2021 Aug; 68(8):e29066. PubMed ID: 33855784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eltrombopag added to immunosuppression for children with treatment-naïve severe aplastic anaemia.
    Groarke EM; Patel BA; Gutierrez-Rodrigues F; Rios O; Lotter J; Baldoni D; St Pierre A; Shalhoub R; Wu CO; Townsley DM; Young NS
    Br J Haematol; 2021 Feb; 192(3):605-614. PubMed ID: 33410523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A real-word experience of eltrombopag plus rabbit antithymocyte immunoglobulin-based IST in Chinese patients with severe aplastic anemia.
    Jin Y; Li R; Lin S; Jia J; Yang Y; Zhang D; He G; Li J
    Ann Hematol; 2022 Nov; 101(11):2413-2419. PubMed ID: 36028583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study.
    Liu Q; Dong H; Li Y; Shen Y; Hong Y; Chen Y; Liu S; Wu X; Liu W; Hu H; Zhao Y; Lin S; Shen Y; Zhou Y; Ye B; Wu D
    Lipids Health Dis; 2022 Oct; 21(1):93. PubMed ID: 36192750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of immunosuppressive therapy combined with eltrombopag for severe aplastic anemia: a systematic review and meta-analysis.
    Zhang Y; Li J; Li X; Geng Q; Xie Y; Zhang G; Wei M; Ma Y
    Syst Rev; 2024 Apr; 13(1):101. PubMed ID: 38576005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
    Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plain language summary of RACE study results: addition of eltrombopag to standard treatment of severe aplastic anemia.
    de Latour RP; Kulasekararaj A; Iacobelli S; Griffin M; Halkes CJ; Dufour C; Risitano AM
    Immunotherapy; 2024 Feb; 16(3):135-142. PubMed ID: 38088156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of combined immunosuppressive therapy plus umbilical cord blood infusion in severe aplastic anemia patients: A cohort study.
    Luo X; Lu H; Xiu B; Wu H; Li B; Li P; Chen Y; Zhou L; Zhang W; Dong Y; Liang A; Ding Y
    Exp Ther Med; 2018 Feb; 15(2):1966-1974. PubMed ID: 29434791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia.
    Zhao Y; Yang W; Zhao X; Hu X; Hu J; Liu X; Li J; Ye L; Xiong Y; Yang Y; Zhang B; Li X; Yang X; Shi Y; Peng G; Li Y; Fan H; Zhou K; Jing L; Zhang L; Zhang F
    Front Pediatr; 2022; 10():1095143. PubMed ID: 36704148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The life span of red blood cell in patients with severe/very severe aplastic anemia].
    Ye L; Guo J; Jing LP; Peng GX; Zhou K; Li Y; Li Y; Li JP; Fan HH; Song L; Zhang FK; Zhang L
    Zhonghua Xue Ye Xue Za Zhi; 2018 Feb; 39(2):137-142. PubMed ID: 29562449
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of concentration of cyclosporine A on the early response to immunosuppressive therapy in severe aplastic anemia].
    Liang LY; Zhang L; Jing LP; Zhou K; Wang XD; Li Y; Peng GX; Li Y; Li JP; Shi LH; Ye L; Fan HH; Zhang P; Chu YL; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):766-71. PubMed ID: 22339914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matched related transplantation versus immunosuppressive therapy plus eltrombopag for first-line treatment of severe aplastic anemia: a multicenter, prospective study.
    Liu L; Lei M; Fu R; Han B; Zhao X; Liu R; Zhang Y; Jiao W; Miao M; Zhang F; Zhang L; Wu D
    J Hematol Oncol; 2022 Aug; 15(1):105. PubMed ID: 35962406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged use of eltrombopag in patients with severe aplastic anemia in the real world.
    Li R; Wang N; Chai X; Yang L; Liu K; He H; Lin S; Yang Y; Jia J; Zhang D; Gong Y; Shi J; He G; Li J
    Clin Exp Med; 2023 Oct; 23(6):2619-2627. PubMed ID: 36645546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.